
The Society
More than 35,000 clinicians, scientists and allied health professionals from over 160 countries are part of the ERS community
Become an ERS member

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
Other cookies are those that are being identified and have not been classified into any category as yet.
1–2 June, 2023 | Brussels, Belgium | #dragoncovid2023
As the culminating event of the three-year EU-funded DRAGON project focusing on SARS-CoV-2 and COVID-19, the conference in June 2023 brought together experts to discuss clinical networks, the implementation of diagnosis/prediction models – including artificial intelligence – in acute and long COVID, as well as pandemic preparedness.
Held both in-person and online, this event was developed in collaboration with the European Respiratory Society (ERS) as part of the DRAGON IMI project.
The DRAGON project is coordinated by the University of Maastricht with Radiomics as the Project Lead, and partners comprised of high-tech small and medium-sized enterprises (SMEs), academic research institutes, biotechnology and pharmacological partners, and ELF and ERS. Funded by the Innovative Medicines Initiative (IMI), it will use AI and machine learning to deliver a patient-centred decision support system that will enable stakeholders to participate in the development of rapid precise diagnosis and prognosis.
“The application of digital imaging together with clinical data to inform clinical decisions through artificial intelligence is very exciting. The DRAGON project offers to do this as part of our response to the pandemic.” – Professor Christopher Brightling, event co-chair